Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q3 2024 Earnings Conference Call October 31, 2024 8:00 AM ET
Company Participants
Tina Ventura – Chief Investor Relations Officer
Bill Sibold – CEO, President & Director
Mardi Dier – CFO & Senior VP
Conference Call Participants
Yasmeen Rahimi – Piper Sandler
Eliana Merle – UBS
Manoj Eradath – Jefferies
Ritu Baral – TD Cowen
Prakhar Agrawal – Cantor Fitzgerald
Jay Olson – Oppenheimer
Thomas Smith – Leerink Partners
Operator
Good day, and thank you for standing by. Welcome to Madrigal Pharmaceuticals Third Quarter 2024 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there will be a question and answer session. As a reminder, today’s conference call is being recorded.
I would now like to introduce Ms. Tina Ventura, Chief Investor Relations Officer. Please go ahead.
Tina Ventura
Thank you, Mervin. Good morning, everyone, and thank you for joining us to discuss Madrigal’s third quarter 2024 earnings. We issued a press release this morning and have a slide deck that accompanies this webcast, which we will post on the Investor Relations section of our website right after the call.
On the call with me today is Bill Sibold, Chief Executive Officer; and Mardi Dier, Chief Financial Officer. They will provide prepared remarks, and then we’ll take your questions. Our goal is to keep today’s call to about 45 minutes.
Please note on Slide 2, we will be making certain forward-looking statements today. We refer you to our SEC filings for a discussion of the risks that may cause actual results to differ from the forward-looking statements.
With that, I will now turn the call over to Bill on Slide 3.
Bill Sibold
Well, thanks, Tina. Good morning, and thanks for joining. I’ll cover three topics on our call this morning. First, an update on the
Read the full article here
